Evidence map›Paper›PMID 36651436›Full record

ReviewJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2023

Environmental impact of inhaler devices on respiratory care: a narrative review.

Marilyn Urrutia-Pereira, Herberto José Chong-Neto, Tonya A Winders, Dirceu Solé

Open access · diamondAbstract readReview
In one paragraph

Review in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Observational
  5. Observational
  6. Review
  7. Review
  8. Choice of inhaler device and its disposal have a significant impact on the environment.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Marilyn Urrutia-Pereira. Departamento de Medicina, Universidade Federal do Pampa, Uruguaiana (RS) Brasil.ORCID 0000-0001-6575-7897
Herberto José Chong-Neto. Departamento de Pediatria, Universidade Federal do Paraná, Curitiba (PR) Brasil.ORCID 0000-0002-7960-3925
Tonya A Winders. Global Allergy and Airways Patient Platform, Vienna, Austria.ORCID 0000-0001-7689-6438
Dirceu Solé. Departamento de Pediatria, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo (SP) Brasil.ORCID 0000-0002-3579-0861
Associação Paulista de Medicina · BREuropean Federation of Allergy and Airways Diseases Patients Associations · BEUniversidade Federal do Pampa · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Climate change is a huge and present threat to human health. This article aims to deepen the knowledge about the environmental impact of inhaler devices on their carbon footprint for patients and health professionals, providing information that allows a better choice of the type of device to be prescribed for the treatment of asthma and COPD. This narrative and nonsystematic review was carried out by searching databases (PubMed, Google Scholar, SciELO, and EMBASE) for articles published between 2017 and 2022, written in Portuguese or in English, using the search words "inhalation device" OR "environmental." The review showed that global warming cannot be addressed by focusing only on inhaler devices. However, the devices that we use to treat respiratory diseases such as asthma and COPD, which are diseases that are aggravated by climate change, are also causing that change. Therefore, health professionals, patient organizations, and industries should take a lead in health policies to offer affordable alternatives to inhalers containing hydrofluoroalkane.

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveAdministration, InhalationBronchodilator AgentsEnvironmentHumansNebulizers and VaporizersBronchodilator Agents

Identifiers

PMID36651436
PMCPMC9747156
OpenAlexW4308995621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.